The Discounted Cash Flow (DCF) valuation of West Pharmaceutical Services Inc (WST) is 229.15 USD. With the latest stock price at 224.01 USD, the upside of West Pharmaceutical Services Inc based on DCF is 2.3%.
Based on the latest price of 224.01 USD and our DCF valuation, West Pharmaceutical Services Inc (WST) is a buy. buying WST stocks now will result in a potential gain of 2.3%.
| Range | Selected | |
| WACC / Discount Rate | 7.0% - 9.7% | 8.4% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 155.11 - 473.54 | 229.15 |
| Upside | -30.8% - 111.4% | 2.3% |